Events
Life Sciences & Health Care Tax Hot Topics Seminar Invitation
16 October 2020 | Shanghai
With the advance of the new medical reform, the PRC central government and local governments have introduced some industry-specific support and encouraging policies including tax incentives. Among them, the new policy of the Hainan Free Trade Port has aroused heated discussions in the industry. How to effectively utilize the relevant policies to maximize the incentives, and at the same time, to reduce the tax costs while meeting the group's business strategy by optimizing the supply chain is a significant issue that the enterprises need to consider.
Deloitte will host a seminar on Oct.16th in Shanghai, which will start by introducing the core medical reform policies, focus on the impact of medical reform on the Life Sciences & Health Care industry from the aspects of PRC taxation, customs and foreign exchange control, and discuss overall tax optimization for Life Sciences & Health Care enterprises against the backdrop of governments' support and encouraging policies. To this end, we have invited government officials from Hainan province to take a deep dive into the Master Plan for the Construction of Hainan Free Trade Port, and tax and customs experts from Deloitte China will share their insights on the above mentioned topics.
Agenda:
Duration |
Topics |
13:30 – 14:00 |
Registration and networking |
14:00 – 14:10 |
Opening speech Jens Ewert, Deloitte China Life Sciences & Health Care Industry Leader |
14:10 – 14:55 |
Tax challenges and opportunities under the medical reform, and overview of the key points in governments' industry support and enterprise's market entry James Zhao, Deloitte China Life Sciences & Health Care Industry Tax Leader Jeff Xu, Deloitte China Government & Public Services Industry Tax Leader |
14:55 – 15:35 |
New investment opportunities in Hainan Free Trade Port Government officials from Hainan |
15:35 – 15:50 |
Coffee break |
15:50 – 16:30 |
Customs' supervision trend on life sciences industry Dolly Zhang, Deloitte China Indirect Tax Partner |
16:30 – 16:50 |
Q&A – Panel Government officials from Hainan & Deloitte Tax Partner |
16:50 – 17:00 |
Closing James Zhao, Deloitte China Life Sciences & Health Care Industry Tax Leader |
Time: 16 October 2020 (Friday), 13:30-17:00.
Venue: 30/F, Bund Center, 222 Yan'an East Road, Shanghai
Language: Chinese & English
Fee: Free
Registration: This seminar has limited seats, with a maximum of two attendees per company. Please provide the information (Company, Name, Title and Phone No. and Email) to Summer Yang to reserve your seat as soon as possible. Recommended participants: Chief Financial Officers, Financial Directors, and Tax Directors from pharmaceutical and medical device companies.
We will close the registration by next Monday, 12 October 2020.
Contacts
Summer Yang
Direct:+86 21 2316 6570
E-mail:sumyang@deloitte.com.cn
Recommendations
The future awakens
Life Sciences and Health Care Predictions 2022
2018 global health care sector outlook
The evolution of smart health care